Letters to the Editor

Venetoclax as monotherapy and in combination with hypomethylating agents or low dose cytarabine in relapsed and treatment refractory acute myeloid leukemia: a systematic review and meta-analysis

Yale University;
Division of Hematology and Oncology, University of Alabama School of Medicine;
Department of Chronic Disease Epidemiology, School of Public Health, Yale University;
Rockefeller University;
Memorial Hospital;
Yale University;
Memorial Sloan Kettering Cancer Center
Vol. 105 No. 11 (2020): November, 2020 https://doi.org/10.3324/haematol.2019.242826